Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ASMB
Stock Latest News
Pre-Earnings
Is ASMB a Buy, Before Earnings?
14d ago
ASMB
Premium
Ratings
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
3M ago
ASMB
Premium
The Fly
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
3M ago
ASMB
GILD
Premium
The Fly
Gilead exercises option to license Assembly helicase-primase inhibitor programs
3M ago
ASMB
GILD
Premium
Company Announcements
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
3M ago
ASMB
Premium
Ratings
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
3M ago
ASMB
Premium
Company Announcements
Assembly Biosciences Reports Positive Phase 1b Results
3M ago
8K
ASMB
Premium
The Fly
Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials
3M ago
ASMB
GILD
Premium
The Fly
Assembly Biosciences price target raised to $40 from $29 at Mizuho
4M ago
ASMB
Premium
Ratings
Assembly Biosciences: Strong Clinical Execution and Strategic Partnerships Drive Buy Rating
4M ago
ASMB
Premium
Company Announcements
Assembly Biosciences Inc. Reports Q3 2025 Earnings
4M ago
ASMB
Premium
The Fly
Assembly Biosciences reports Q3 EPS (72c), consensus (65c)
4M ago
ASMB
Premium
The Fly
Assembly Biosciences announces Phase 1b data for ABI-4334
4M ago
ASMB
Premium
Pre-Earnings
ASMB Earnings this Week: How Will it Perform?
4M ago
ASMB
Premium
Company Announcements
Assembly Biosciences Advances HSV-2 Treatment Study with ABI-1179
5M ago
ASMB
Premium
Company Announcements
Assembly Biosciences’ Promising HSV-2 Treatment Study: Key Insights for Investors
5M ago
ASMB
Premium
Company Announcements
Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment
5M ago
ASMB
Premium
The Fly
Assembly Biosciences files to sell 6.98M shares of commons stock for holders
5M ago
ASMB
Premium
Ratings
Promising Phase 1b Results for ABI-5366 Drive Buy Rating for Assembly Biosciences
5M ago
ASMB
Premium
The Fly
Assembly Biosciences presents interim Phase 1b data for ABI-5366
5M ago
ASMB
Premium
The Fly
Amazon upgraded, Adobe downgraded: Wall Street’s top analyst calls
6M ago
BE
GM
Premium
The Fly
Assembly Biosciences initiated with an Outperform at Citizens JMP
6M ago
ASMB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
